The Long/Short Equity spread of AKRX/PKD has just broken out to a new high and finished Friday's trading session at the high of 12.82.
Akorn Inc (pharmaceuticals) has reported consistently good earnings with an EPS change of 80% in the last quarter and also an annual ROE (Return on Equity) of 27.1%. It trades at a slightly higher P/E ratio of 48 which has been...